Overview: Biotinylated Monoclonal Antibodies: Their Potential for Diagnosis and Therapy of Cancer

References

• KOHLERG, MILSTEINC : Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature (1975) 256:495–497.
   PubMed Web of Science ®Google Scholar
• YELTOND E, SCHARFMF D: Monoclonal anti-bodies: a powerful new tool in biology and medicine. Annu. Rev. Biochem. (1981) 50:657–680.
   PubMed Web of Science ®Google Scholar
• MACH JP, BUCHEGGER F, FORNI M, BUCHEGGE F, RITSCHAR J, BERCHE C, LUMBROSO JD, SCHREYER M, GIRARDET C, ACCOLLA RS, CARREL S: Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinoma by external photoscan-ning and tomoscindgraphy. Immunol. Today (1981) 2:239–249.
   PubMedGoogle Scholar
• EPENETOS AA, BRITTON ICE, MATHER S. SHEPHERD J, GFtANOWSKA M, TAYLOR-PAPA-DLMITRIOU J, NIMMON CC, DURBIN M, HAWKENS LR, MALPAS IS, BODMER WS: Targeting of 123iodine-labelled tumor associated mono-clonal antibodies to ovarian, breast, and gas-trointestinal tumours. Lancet (1982) ii:999–1004.
   Google Scholar
• HNATOWICH DJ, LAYNE WW, CHILDS RL : The preparation and labelling of DTPA cou-pled albumin. Int. J. Appl. Radiat. Isotop. (1982) 33:327–332.
   PubMedGoogle Scholar
• KOZAK RW, RAUBUTSCHEK A, MIRZADEH S. BRECHBIEL MW, JUNGHAUS R, GANSOW OA, WALDMAN TA: Nature of bifunctional chelating agent used in radioimmunother-apy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo sur-vival and organ toxicity. Cancer Res. (1989) 49:2639–2644.
   Google Scholar
• OTT RJ, GREY Li, ZIVANOIC MA, FLOKER MA, TROTT NG, MOSCHAKIS V. COOMBES RC, NEVELLE AM, ORMEROD MG, WESTWOOD JH: The limitations of the dual radionuclide sub-traction technique for the external detection of tumor by radioiodine-labeled antibodies. Br J. Radiol. (1983) 56:101–108.
   PubMed Web of Science ®Google Scholar
• WEENSTEIN JN, PARKER RJ, KEENAN AM, DOWER SK, MORSE HC III SIEBER SM MONOCLONAL ANTIBODIES IN THE LYMPHATIC: Towards the diagnosis and therapy of tumor metastases. Science (1982) 218:1334–1337.
   PubMed Web of Science ®Google Scholar
• PAGANELLI G, RIVA P, MOSCATELLI G, STAC-CHIOTTI A, AGOSTIN1 ME, LANDI G, TISON V, PANACEA P, SICCARDI AG: Improved immunoscintigraphy by subcutaneous injec-tion of 99111Tc- or 1111n-labelled F(ab')2 frag-ments of an anti-melanoma monoclonal an-tibody. Int. J. Nucl. Med. Biol. (1986) 13:423–428.
   Google Scholar
• ROWLINSON G, SNOOK D, BUSZA A, EPENETOS AA: Antibody guided localisation of in-traperitoneal tumors following intraperi-tonesl or intravenous antibody administra-tion. Cancer Res. (1987) 47:6528–6531.
   PubMed Web of Science ®Google Scholar
• BEGEN'T RHJ, GREEN AJ, BAGSHAWE KD, JONES BE, KEEP PA, SEARLE F, JEWKES RF, BARRAT GM, RYMAN BE: Liposomally en-trapped second antibody improves tumor imaging with radiolabelled (first) antitumor antibody. Lancet (1982) 11:739–742.
   Google Scholar
• BRADWELL AR, VAUGHAN A, FAIRWEATHER DS, DYKES PW: Improved radioimmunode-tection of tumours using second antibody. Lancet (1983) 1:247–252.
   PubMed Web of Science ®Google Scholar
• HASEMAN MK, GOODWIN DA, MEARES CF, KAmiNsKi MS, WENSEL TG, McCALL MJ, LEVY R: Metabolizable 111In chelate con-jugated anti-idiotype monoclonal antibody for radioimmunodetection of lymphoma in mice. Eur. J. Nucl. Med. (1986) 12:455–460.
   PubMedGoogle Scholar
• PAIK CH, YOKOYAMA K. REYNOLDS JC, QUADRI SM, MIN CY, SHIN SY, MALONEY PJ, LARSON SM, REBA RC: Reduction of back-ground activities by introduction of a di-ester linkage between antibody and a chelate in radioimmunodetection of tumor. J. Nucl. Med. (1989) 30:1693–1701.
   PubMed Web of Science ®Google Scholar
• LARSON SM, CARRASQUILLO JA, MCGUFFIN RW, KROHN KA, FERENS JM, HILL LD, BEAUMIER PL, REYNOLDS JC„ HELLSTROM KE, HELLSTROM I : Use of 131I-labelled murine Fab' against a high molecular weight antigen of human melanoma: preliminary experience. Radiology (1985) 155:487–492.
   PubMed Web of Science ®Google Scholar
• DELALOYE B, BISCHOF-DELALOYE A, BUCHEG-GER F, FLIEDNER V. GROB JP, VOLANT JC, PETTAVEL J, MACH JP: Detection of colore-lated carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(a13`)2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. J. Clin. Invest (1986) 77:301–311.
   PubMed Web of Science ®Google Scholar
• GOLDENBERG DM, WLOODKOWSKI Ti, SHARKEY RM, SEBERSTEIN EB, SERAFIN1 AN, GARTY II, VAN HAERTUM RL, HIGGINBOTHAM-FORD EA, KOTLER JA, BALASUBRAMANIAN H, SWAYNE LC, HANSEN HJ, PINSKY CM : Colorec-tal cancer imaging with Iodine-1 23-labeled CEA monoclonal antibody fragments. J. Nucl. Med. (1993) 34:61–70.
   PubMed Web of Science ®Google Scholar
• MILSTEIN C, CUELO AC: Hybrid hybridoma and thier use in immunohistochemistry. Na-ture (1983) 305:537–540.
   PubMed Web of Science ®Google Scholar
• BRENNAN M, DAVISON PF, PAuLusH: Prepa-ration of bispecific antibodies by chemical recombination of monoclonal immunoglob-ulin G1 fragments. Science (1985) 229:81–83.
   PubMed Web of Science ®Google Scholar
• LE DOUSSAL JM, MARTIN M, GAUTHEROT E, DELAAGE M, BARBET J: In vitro and in vivo targeting of radiolabelled monovalent and divalent haptens with dual specificity mono-clonal antibody conjugates: enhanced diva-lent hapten affinity for cell-bound antibody conjugate. J. Nucl. Med. (1989) 30:1358–1366.
   PubMed Web of Science ®Google Scholar
• STICKNEY DR, SLATER JB, KIRK GA, MERCH-ANT B, SCHWEIGHARDT SA, FRINKE JM: A bi-functional antibody delivery system: clini-cal studies demonstrate imaging and thera-peutic potential. J. NucL Med. (1990) 31:734 (abs.).
   Google Scholar
• WILCHEK M, BAYER EA: The avidin-biotin complex in bioanalytical applications. Ana-lytical Biochem (1988) 171:1–32.
   PubMed Web of Science ®Google Scholar
• WILCHEK M, BAYER EA (EDs): Avidin-biotin technology, Methods in Enzymology (1990), vol. 184, Academic Press, N.Y.
   Google Scholar
• GREEN NM : Avidin. Adv. Prot. Chem. (1975) 29:85–
   Google Scholar
• GREEN NM: Avidin - 1. The use of 14C biotinfor kinetic studies and for assay. Biochem. J. (1963) 89:585–591.
   Google Scholar
• WOOLLEY DW, LONGSWORTH LG: Isolation of an antibiotin factor from egg white. J. Biol. Chem. (1942) 142:285–290.
   Google Scholar
• KORPELA JK, KULOMA MS, ELO HA, TUOIIIA-MAA PJ : Biotin binding proteins in eggs of oviparous vertebrates. Experientia (1981) 37:1065–1066.
   PubMedGoogle Scholar
• STAPLEY EO, MATA JM, MILLER IM, DENNY TC, WOODRUFF HB: Antibiotic MSD-235- I. Production by Streptomyces avidinii and Streptomyces lavandulae. Antimicrob. Ag. Che-mother. (1963) 3:20–27.
   Google Scholar
• DITTMER J, DITTMER A, DELLA BRLTNA R, KASCHE V: A native, affinity based protein blot for the analysis of streptavidin hetero-geneity: consequences for the specificity of streptavidin mediated binding assays. Elec-trophoresis (1989) 10:762–765.
   PubMed Web of Science ®Google Scholar
• BRUCH RC, WHITE HB: III Composi-tional and structural heterogeneity of avidin glycopeptides. Biochemistry (1982) 21:5334–5341.
   PubMed Web of Science ®Google Scholar
• METHODS IN ENZYMOLOGY: Avidin-Biotin-Technology (1990) 184 Meir Wilchek and Edward Bayer (Eds). Accademic Press. San Diego, USA p 70.
   Google Scholar
• GATTI G, BOLOGNESI M, CODA A, CHIOLERIO F, FILIPPINI F, MALCOVATI M: Crystallisation of hen egg-white avidin in a tetragonal form. J. Mol. Biol. (1984) 178:787–789.
   PubMed Web of Science ®Google Scholar
• PAHLER A, HENDRICKSON WA, GAWINOWICZ LOLKS MA, ARGARANA CE, CANTOR CR: Characterisation and crystallisation of core streptavidin. J. Biol. Chem. (1987) 262:13933–13937.
   PubMed Web of Science ®Google Scholar
• PAGANELLI G, PERVEZ S. SICCARDI AG, ROWLINSON G, DELEIDE G, CHIOLERIO F, MALCOVATI M, SCASSELLATI GA, EPENETOS AA: Intraperitoneal radio-localisation of tumours pre-targeted by biotinylated mon-oclonal antibodies. Int. J. Cancer (1990) 45:1184–1189.
   PubMed Web of Science ®Google Scholar
• PAGANELLI G, RIVA P. DELEIDE G, CLIVIO A, CHIOLERIO F, SCASSELLATI GA, MALCOVATI M, SICCARDI AG: In vivo labelling of biotiny-lated antibodies by radioactive avidin: a strategy to increase tumour radiolocalisa-tion. Int. J. Cancer (1988) 2:121-125 (Suppl.).
   Google Scholar
• KALOFONOS HP, RUSCKOWSKI M, SIEBECKER DA, SIVOLAPENKO GB, SNOOK D, LAVENDER _ JP, EPENETOS AA, AND HNATOWICH DJ: Imaging of tumor in patients with 111Indium-labelled biotin and streptavidin-conjugated antibodies: preliminary communication. J Nucl. Med. (1990) 31:1791. The first study in patients using Streptavidin conjugate antibodies. However no 'chase' was used prior to II 'In-biotin injection.
   Google Scholar
• PAGANELLI G. MAGNANI P. ZITO F, VILLA E. SUDATI F, LOPALCO L, ROSSETTI C, MALCOVATI M, CHIOLERIO F, SECCAMANI E, SICCARDI AG AND FAZIO F: Three-step monoclonal anti-body tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. (1991) 51:5960. The first study in patients using the three step approach (B). This protocol has been optimized and advantages and disadvantages of the method are discussed.
   Google Scholar
• PAGANELLI G. BELLONI C, MAGNANI P. ZITO F, PASINI A, SASS 1, MERONI M, MARIAN! M, VIGNALI M, SICCARDI AG, AND FAZIO F: Two-step tumour targeting in ovarian can-cer patients using biotinylated monoclonal antibodies and radioactive streptavidin. Eur. J. Nucl. Med.(1992) 19:322.
   PubMedGoogle Scholar
• YOUNG RC, KNAPP RC, AND PEREZ CA: Can-cer of the ovary. In Cancer (1982): In: Princi-ples and Practice of Oncology. De Vita VT Jr, Hellman S, Rosenberg SA (Eds), Philadelphia: 884.
   Google Scholar
• STEWART JSW, HIRD V, SNOOK D, SULLIVAN M, HOOKER G, COURTENAY-LUCK N, STIVOLA-PENKO G, GRIFFTTHS M, MYERS MJ, LAMBERT HE, MUNRO J, EPENETOS AA: Intraperitoneal radioinununotheraphy for ovarian cancer: pharmacokinetics, toxicity, and efficacy of-131 labeled monoclonal antibodies. Int. J. Ra-diat. Oncol. Biol. Phys.(1989) 16:405.
   PubMed Web of Science ®Google Scholar
• HIRD V, STEWART JSW, SNOOK D, BHOKIA B, COULTER C, LAMBERT HE, MASON WP, SourrER WP, EPENE'TOS AA: Intraperitoneally administered 90Y-labelled monoclonal anti-bodies as a third line of treatment in ovar-ian cancer. A phase 1–2 trial: problems en-countered and possible solutions. Br J Can-cer (1990) 62, (suppl. X):48.
   Google Scholar
• COLCHER D, ESTEBAN J, CARASQUILLO JA, SUGARBAKER P, REYNOLDS JC, BRYANT G, LARSON SM, SCHLOM J: Complementation of intracavitary and intravenous adminis-tration of a monoclonal antibody (B72.3) in patients with carcinoma. Cancer Res. (1987) 47:4218.
   PubMed Web of Science ®Google Scholar
• WARD BG, MATHER SJ, HAWKINS LR, CROW-THER ME, SHEPHERD JH, GRANOWSKA M, BRITTON KE AND SLEVIN ML: Localization of radioiodine conjugated to the monoclonal antibody HMFG 2 in human ovarian card-noma: assessment of intravenous and intra-peritoneal routes of administration. Cancer Res (1987) 47:4719.
   PubMed Web of Science ®Google Scholar
• JAIN RK: Determinants of tumor blood flow:a review. Cancer Res (1988) 48:2641.
   PubMed Web of Science ®Google Scholar
• BOMANJI J, GARNER A, PRASAD J, ALBERT DM, HUNGERFORD JL, GRANOWSKA M AND BiurroN KE: Characterisation of ocular melanoma with cutaneous melanoma anti-bodies. Br. J. Ophthalmol. (1987) 71:647.
   PubMed Web of Science ®Google Scholar
• SCHEIDHAUER K, MARICL A, LEINSINGER G, MOSER E. SCHEIFFARTH OF, RIEDEL KG, SCHAAL TS, STEFANI FH AND SCHUMACHER U: bmnunoscintigraphy in intraocular malig-nant melanoma. Nucl. Med. Commun. (1988) 9:669.
   PubMedGoogle Scholar
• MAGNANI P, PAGANELLI G, MODORATI G, SONGINI C, ZITO F, PAVONI R, SUDATI F, KOCH P, FAZIO F: Radioimmtmoscintigraphy with 3-STEP monoclonal antibody pretargeting technique in uveal melanoma. The Journal of Nuclear Medicine (1992) 335:959.
   Google Scholar
• JAIN KR AND BAXTER LT: Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tu-mors: significance of elevated interstitial pressure. Cancer Res. (1988) 48:7022.
   PubMed Web of Science ®Google Scholar
• VAN OSDOL W. FUJIMORI K. AND WEINSTEIN JN: An analysis of monoclonal antibody dis-tribution in microscopic tumor nodules: con-sequences of a 'binding site barrier'. Cancer Res. (1991) 51:4776. Both references [48] and [49] are useful for understanding the mechanism of biodistribution and pharmokinetics of monoclonal antibodies.
   Google Scholar
• FUJIMORI K, COVELL DG, FLETCHER J., AND WEINSTEIN JN: A modeling analysis of mon-oclonal antibody percolation through tu-mors: a binding-site barrier. J. NucL Med. (1990) 31:1191.
   Google Scholar
• Su-MING HSU, RAINE L, AND FANGER H: Useof avidin-biotin peroxidase complex (ABC) in inununoperoxidase techniques: a compar-ison between ABC and unlabeled antibody (PAP) procedures. J. Hist. Cyt. (1981) 29:577.
   PubMed Web of Science ®Google Scholar